CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018

Go back to CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
Cytosorbents Corporation (NASDAQ: CTSO) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $7.48 
Open $0.36    52 Week Low $3.11 
Day High $0.36    P/E N/A 
Day Low $0.36    EPS $-0.03 
Volume 102